
Dataset Title: Structural Mapping of Amyloidogenic and Neurodegenerative Disease Targets -- Neuro Research Dataset v1.1 Overview: Focuses on protein misfolding, nucleation, and aggregation pathways in ALS, Alzheimer's, and Parkinson's disease (e.g., HTT, SNCA, LRRK2, APOE4, APP, SOD1). Mapped coordinate structures show expanded ligand cavities to design small-molecule stabilizers that lock the monomeric state and prevent toxic oligomerization. Computational Methodology: Target structures are optimized using the NRC CASP-17 Pure Math Folding Engine. This pipeline applies C-alpha harmonic guide potential constraints ($k_{guide} = 0.5$) for comparative modeling (or $k_{guide} = 0.0$ for ab-initio modeling), followed by sidechain relaxation and pocket expansion simulations to identify allosteric and active cavities. All coordinates are audited using the Trageser Tensor Theorem (TTT-7) lattice-parity verification to eliminate steric clashes (minimum inter-atomic distance > 1.10 Å) and loop hallucinations. License: Distributed under Creative Commons Attribution 4.0 International (CC BY 4.0) to enable open, commercial, and academic therapeutic drug design. Principal Investigator: James Paul Trageser Affiliation: Nexus Resonance Codex ORCID: 0009-0006-6678-2908 X (Twitter): @jtrag Repository: https://GitHub.com/Nexus-Resonance-Codex/Drug-Discovery
Huntington's Disease, huntingtin, TDP-43, Parkinson's disease, alpha-synuclein, Alzheimer's Disease, aggregation inhibitors, neuroinflammation, protein aggregation, drug discovery, neuroscience, lattice collapse prevention, amyloid fibrils, aggregation blockers, nucleation inhibitors, mitochondrial dysfunction, oxidative stress, structural biology, neurodegenerative diseases, Huntingtin, tau, protein misfolding, neuroregeneration, FUS, Parkinson's Disease, neurology, Amyotrophic Lateral Sclerosis, dimer stabilization, neuroprotective agents, neurodegeneration, Huntington's disease, SOD1, Alzheimer's disease, amyloid-beta, neurodegenerative therapy, Amyloid Beta, prion protein, neuroprotection, intrinsically disordered proteins, ALS
Twitter Data
Huntington's Disease, huntingtin, TDP-43, Parkinson's disease, alpha-synuclein, Alzheimer's Disease, aggregation inhibitors, neuroinflammation, protein aggregation, drug discovery, neuroscience, lattice collapse prevention, amyloid fibrils, aggregation blockers, nucleation inhibitors, mitochondrial dysfunction, oxidative stress, structural biology, neurodegenerative diseases, Huntingtin, tau, protein misfolding, neuroregeneration, FUS, Parkinson's Disease, neurology, Amyotrophic Lateral Sclerosis, dimer stabilization, neuroprotective agents, neurodegeneration, Huntington's disease, SOD1, Alzheimer's disease, amyloid-beta, neurodegenerative therapy, Amyloid Beta, prion protein, neuroprotection, intrinsically disordered proteins, ALS
Twitter Data
| citations The total number of citations received by all articles of the researcher of interest. | 40 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
